Li fraumeni | TP53 (only 70%) | 17p13.1 | Transcription factor, apoptosis induction, etc | Many including astrocytomas | Mainly astrocytic | 114, 115 |
Neurofibromatosis type 1 |
NF1
| 17q11.2 | GTPase activating protein homology | Astrocytomas (brain stem optic nerve) ependymomas, PNETs and meningiomas (pheochromocytoma), etc | Unknown | 5, 116 |
Neurofibromatosis type 2 |
NF2
| 22q12.2 | Ezrin/moesin/radixin-like | Vestibular schwannomas, meningiomas, spinal schwannomas | Meningiomas, schwannomas |
117
|
Familial adenomatous polyposis coli (or Turcot syndrome A) |
APC
| 5q21−q22 | Regulates β-catenin | Medulloblastoma | Unknown | 118, 119 |
Hereditary non-polyposis colorectal cancer (or Turcot syndrome B) |
MLH1
| 3p21.3 | Microsatellite instability (MIN+) | Glioblastoma (unknown if all germline mutations are associated with glioblastoma) | Unknown; astrocytic tumours that are MIN+ occur but are uncommon |
118
|
|
MSH2
| 2p22−p21 | | | | |
|
MLH3
| 14q24 | | | | |
|
PMS1
| 2q31−q33 | | | | |
|
PMS2
| 7p22 | | | | |
Basal cell naevus syndrome/Gorlin’s syndrome |
PTCH
| 9q22.3 | Receptor for SHH inhibits SMO | Medulloblastoma | Medulloblastoma |
119
|
Cowden disease (multiple hamartoma syndrome, Lhermitte-Duclos, etc) |
PTEN
| 10q22−q23 | Dual specificity phosphatase and Tensin homology | Astrocytomas reported but tumours in other organs more common—thyroid, breast, female genito-urinary tract | Glioblastomas |
120
|
Melanoma-astrocytoma syndrome |
CDKN2A/p14ARF
| 9p21 | Cell cycle control (G1-S)/p53 level control | Astrocytomas | Astrocytic |
121
|